NCT00466791View on ClinicalTrials.gov

Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD

PHASE2CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Methylphenidate Transdermal System

Placebo

Trial Locations (1)

92612

UCI Child Development Center, Irvine

Sponsors

Lead Sponsor

Noven Therapeutics
All Listed Sponsors
lead

Noven Therapeutics

INDUSTRY